ASX - By Stock
|
PTX |
Re:
Pitt St Research Report...
|
|
dalts66
|
25 |
12K |
12 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
25
|
12K
|
12
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
13 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
533
|
262K
|
13
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
7 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
533
|
262K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Pitt St Research Report...
|
|
dalts66
|
25 |
12K |
12 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
25
|
12K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dalts66
|
452 |
163K |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
452
|
163K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Pitt St Research Report...
|
|
dalts66
|
25 |
12K |
19 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
25
|
12K
|
19
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
6 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
533
|
262K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
8 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
533
|
262K
|
8
|
|
ASX - By Stock
|
PTX |
Re:
Pitt St Research Report...
|
|
dalts66
|
25 |
12K |
10 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
25
|
12K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
10 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
533
|
262K
|
10
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
dalts66
|
1.0K |
313K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
1.0K
|
313K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
17 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
533
|
262K
|
17
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
dalts66
|
1.0K |
313K |
5 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
1.0K
|
313K
|
5
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
533
|
262K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
15 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
533
|
262K
|
15
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
12 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
533
|
262K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
887 |
350K |
5 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
887
|
350K
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
dalts66
|
22K |
7.9M |
15 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
22K
|
7.9M
|
15
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dalts66
|
452 |
163K |
6 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
452
|
163K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dalts66
|
452 |
163K |
3 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
452
|
163K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
8 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
56
|
20K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
4 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
56
|
20K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
15 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
56
|
20K
|
15
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
19 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
533
|
262K
|
19
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
dalts66
|
3.5K |
1.0M |
7 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 abstract published online on ASH website
|
|
dalts66
|
24 |
8.3K |
11 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
24
|
8.3K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
19 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
56
|
20K
|
19
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 abstract published online on ASH website
|
|
dalts66
|
24 |
8.3K |
6 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
24
|
8.3K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 abstract published online on ASH website
|
|
dalts66
|
24 |
8.3K |
11 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
24
|
8.3K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 abstract published online on ASH website
|
|
dalts66
|
24 |
8.3K |
13 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
24
|
8.3K
|
13
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 abstract published online on ASH website
|
|
dalts66
|
24 |
8.3K |
8 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
24
|
8.3K
|
8
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
dalts66
|
533 |
262K |
27 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
533
|
262K
|
27
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
3 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
56
|
20K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
dalts66
|
3.5K |
1.0M |
4 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
56
|
20K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Publication of final Long COVID data for ATL1102
|
|
dalts66
|
8 |
3.7K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
8
|
3.7K
|
0
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
dalts66
|
3.5K |
1.0M |
13 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
13
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
dalts66
|
3.5K |
1.0M |
23 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
23
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
dalts66
|
3.5K |
1.0M |
2 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
56
|
20K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
56
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
21 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
56
|
20K
|
21
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
9 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
56
|
20K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
56
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
4 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
56
|
20K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
dalts66
|
56 |
20K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
56
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
887 |
350K |
1 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
887
|
350K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
dalts66
|
413 |
168K |
6 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
413
|
168K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
887 |
350K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
887
|
350K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
dalts66
|
1.6K |
674K |
4 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
1.6K
|
674K
|
4
|
|